TrialInternational journal of colorectal disease2021

Randomized phase II study of tegafur-uracil/leucovorin versus tegafur-uracil/leucovorin plus oxaliplatin after curative resection of high-risk stage II/III colorectal cancer (SOAC-1101 trial).

Chihiro Kosugi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.